HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Yao Selected Research

Carcinoma (Carcinomatosis)

1/2015Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells.
1/2014Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.
11/2005[Inhibition of eIF families expression and angiogenesis for human laryngeal carcinoma by elemene administration].
6/2003[Exogenous expression of SOCS box-deficient mutant ASB-8 suppresses the growth of lung adenocarcinoma SPC-A1 cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Yao Research Topics

Disease

158Neoplasms (Cancer)
01/2024 - 01/2002
68Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2002
62Neoplasm Metastasis (Metastasis)
01/2023 - 08/2002
51Pain (Aches)
04/2024 - 05/2006
21Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 03/2006
19Hyperalgesia
03/2024 - 08/2014
16Infections
03/2024 - 06/2010
15Inflammation (Inflammations)
03/2024 - 02/2015
14Bone Neoplasms (Bone Cancer)
03/2024 - 07/2011
14Herpes Zoster
01/2024 - 01/2020
14Carcinogenesis
01/2022 - 08/2010
13Lung Neoplasms (Lung Cancer)
11/2020 - 06/2003
12Neuralgia (Stump Neuralgia)
08/2023 - 11/2011
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 05/2014
10Breast Neoplasms (Breast Cancer)
02/2021 - 01/2011
9Hypoxia (Hypoxemia)
12/2023 - 12/2011
9Postherpetic Neuralgia
10/2022 - 01/2020
9Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2015
8Ischemic Stroke
12/2022 - 10/2011
8Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2021 - 09/2007
7Stroke (Strokes)
02/2024 - 01/2002
7Lymphoma (Lymphomas)
01/2024 - 06/2014
7Hyperhidrosis
12/2023 - 10/2011
7Trigeminal Neuralgia (Tic Douloureux)
10/2023 - 08/2014
7Adenocarcinoma of Lung
11/2020 - 06/2005
7Liver Neoplasms (Liver Cancer)
11/2019 - 11/2013
6COVID-19
03/2024 - 11/2020
6Disease Progression
01/2020 - 07/2005
5Diabetes Mellitus
01/2024 - 02/2014
5Hypersensitivity (Allergy)
05/2022 - 11/2011
5Multiple Myeloma
03/2022 - 09/2003
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 04/2014
4Fever (Fevers)
05/2022 - 05/2011
4Hematologic Neoplasms (Hematological Malignancy)
03/2022 - 05/2011
4Burns
01/2021 - 12/2013
4Stomach Neoplasms (Stomach Cancer)
03/2020 - 08/2002
4Leukemia
02/2019 - 05/2009
4Glioma (Gliomas)
01/2019 - 04/2010
4Hepatitis B
01/2018 - 06/2014

Drug/Important Bio-Agent (IBA)

46Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2002
19MicroRNAs (MicroRNA)IBA
01/2021 - 03/2010
16Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2011
13Interleukin-6 (Interleukin 6)IBA
01/2024 - 11/2011
13CytokinesIBA
01/2024 - 07/2003
13Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023 - 12/2003
13ErbB Receptors (EGF Receptor)IBA
01/2020 - 01/2002
11DNA (Deoxyribonucleic Acid)IBA
01/2024 - 01/2002
10Long Noncoding RNAIBA
01/2024 - 01/2017
10Messenger RNA (mRNA)IBA
01/2021 - 04/2010
9Analgesics (Analgesic Drugs)IBA
03/2024 - 05/2006
9Small Interfering RNA (siRNA)IBA
01/2022 - 06/2005
8Epidermal Growth Factor (EGF)IBA
02/2024 - 01/2002
8RNA (Ribonucleic Acid)IBA
01/2024 - 08/2005
8Cisplatin (Platino)FDA LinkGeneric
01/2020 - 11/2005
7Sorafenib (BAY 43-9006)FDA Link
01/2022 - 06/2012
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 11/2005
6Monoclonal AntibodiesIBA
01/2024 - 07/2003
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 11/2005
6Oxygen (Dioxygen)IBA
02/2023 - 12/2013
6Therapeutic UsesIBA
10/2022 - 02/2018
6C-Reactive ProteinIBA
05/2022 - 05/2011
6LigandsIBA
01/2021 - 07/2003
5Morphine (MS Contin)FDA LinkGeneric
01/2024 - 05/2006
5Blood Glucose (Blood Sugar)IBA
01/2024 - 01/2016
5Rituximab (Mabthera)FDA Link
12/2023 - 06/2014
5Indicators and Reagents (Reagents)IBA
08/2023 - 11/2010
5Glucose (Dextrose)FDA LinkGeneric
12/2021 - 09/2013
5Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021 - 04/2010
5Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 10/2010
5Carrier Proteins (Binding Protein)IBA
01/2019 - 02/2014
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2018 - 09/2002
5Phosphotransferases (Kinase)IBA
01/2018 - 10/2010
5Transcription Factors (Transcription Factor)IBA
11/2017 - 12/2014
5isocorydineIBA
02/2017 - 01/2012
5Adenosine Triphosphate (ATP)IBA
04/2016 - 12/2008
4VaccinesIBA
03/2024 - 07/2013
4ChemokinesIBA
10/2023 - 01/2016
4NF-kappa B (NF-kB)IBA
10/2021 - 06/2010
4CateninsIBA
01/2021 - 01/2016
4UbiquitinIBA
01/2021 - 04/2010
4EnzymesIBA
06/2020 - 11/2013
4ParaffinIBA
12/2019 - 11/2005
4Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2019 - 06/2014
4p38 Mitogen-Activated Protein KinasesIBA
01/2019 - 01/2016

Therapy/Procedure

59Therapeutics
03/2024 - 09/2002
21Drug Therapy (Chemotherapy)
11/2023 - 01/2004
14Hematopoietic Stem Cell Transplantation
03/2024 - 09/2007
11Electrocoagulation (Electrocautery)
10/2023 - 08/2014
10Transplantation
11/2023 - 09/2007
10Punctures
11/2022 - 10/2011
9Analgesia
01/2023 - 10/2012
8Spinal Injections
01/2024 - 10/2012
8Aftercare (After-Treatment)
01/2023 - 11/2018
7Radiofrequency Ablation
11/2022 - 01/2019
6Sympathectomy (Sympathectomies)
12/2023 - 01/2021
5Immunotherapy
01/2022 - 11/2018
5Radiotherapy
05/2021 - 01/2004
5Induction Chemotherapy
01/2021 - 04/2007
4Radiofrequency Therapy
11/2023 - 01/2020
4Stem Cell Transplantation
01/2022 - 11/2018